Tactile Systems Technology (TCMD) Set to Announce Quarterly Earnings on Monday

Tactile Systems Technology (NASDAQ:TCMD) is scheduled to announce its earnings results after the market closes on Monday, November 4th. Analysts expect the company to announce earnings of $0.18 per share for the quarter. Individual interested in participating in the company’s earnings conference call can do so using this link.

Tactile Systems Technology (NASDAQ:TCMD) last released its earnings results on Monday, August 5th. The company reported $0.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.10 by $0.10. The company had revenue of $73.22 million for the quarter, compared to analyst estimates of $72.62 million. Tactile Systems Technology had a net margin of 11.57% and a return on equity of 16.94%. On average, analysts expect Tactile Systems Technology to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Tactile Systems Technology Stock Performance

NASDAQ:TCMD opened at $14.20 on Monday. Tactile Systems Technology has a 52 week low of $9.69 and a 52 week high of $16.95. The company has a fifty day simple moving average of $13.81 and a two-hundred day simple moving average of $13.20. The company has a quick ratio of 3.89, a current ratio of 4.44 and a debt-to-equity ratio of 0.12. The company has a market cap of $337.39 million, a price-to-earnings ratio of 10.29 and a beta of 1.18.

Wall Street Analyst Weigh In

TCMD has been the subject of several analyst reports. StockNews.com raised Tactile Systems Technology from a “buy” rating to a “strong-buy” rating in a research note on Friday, September 20th. B. Riley started coverage on shares of Tactile Systems Technology in a report on Thursday, September 26th. They issued a “buy” rating and a $23.00 target price on the stock.

About Tactile Systems Technology

Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.